ExxonMobil and Synthetic Genomics, Inc. to Brief Media on Algae Research Breakthrough at 2017 BIO International Convention
June 19 2017 - 11:30AM
Business Wire
Scientists from Exxon Mobil Corporation (NYSE:XOM) and Synthetic
Genomics, Inc. will hold a press briefing today at the 2017 BIO
International Convention in San Diego to discuss a breakthrough in
the companies’ research into the development of algae biofuels
involving the modification of an algae strain that more than
doubled its oil production without significantly inhibiting the
strain’s growth. Results of the research were published today in
the peer-reviewed journal Nature Biotechnology. A press release is
available at www.exxonmobil.com and www.syntheticgenomics.com.
Vijay Swarup, vice president for research and development at
ExxonMobil Research & Engineering Company, J. Craig Venter,
Ph.D., co-founder and chairman of Synthetic Genomics, and Oliver
Fetzer, Ph.D., chief executive officer at Synthetic Genomics, will
discuss the research breakthrough and answer questions from
media.
The press briefing is scheduled for 10 a.m. PDT at the San Diego
Convention Center, located at 111 W. Harbor Drive, in Room 32B on
the upper level. The live briefing and replay may also be accessed
online via an interactive webcast.
Cautionary Statement: Statements of
future events or conditions in this release are forward-looking
statements. Actual future results, including the timing, results
and impact of new technologies, could differ significantly
depending on the outcome of further research and testing; the
development and competitiveness of alternative technologies; the
ability to develop and scale pilot projects on a cost-effective
basis; political and regulatory developments; and other factors
discussed in this release and under the heading “Factors Affecting
Future Results” on the Investors page of ExxonMobil’s website at
exxonmobil.com.
About ExxonMobil
ExxonMobil, the largest publicly traded international energy
company, uses technology and innovation to help meet the world’s
growing energy needs. ExxonMobil holds an industry-leading
inventory of resources, is one of the largest refiners and
marketers of petroleum products and its chemical company is one of
the largest in the world. For more information, visit
www.exxonmobil.com or follow us on Twitter
www.twitter.com/exxonmobil.
About Synthetic Genomics
Synthetic Genomics is programming the operating system of life
to create sustainable solutions for humankind’s most pressing
issues, from the wellbeing of our population to the health of our
planet. With an unmatched understanding of how DNA drives the
function of cells — the basic biological units of all living
organisms — Synthetic Genomics modifies and writes genomes to
enable transformative products in the areas of vaccines, medicines,
nutrition, and biotechnology research. In addition to designing
novel organisms that overcome fundamental hurdles of scientific
research and medicine, Synthetic Genomics pursues partnerships with
organizations seeking to dramatically improve upon existing
products in health care, energy, and other sectors. Continuing its
legacy of scientific firsts in genomics and synthetic biology,
Synthetic Genomics is harnessing the power of nature to improve
quality of life. More information is available
at www.syntheticgenomics.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170619005825/en/
ExxonMobilMedia Relations, 972-444-1107orSynthetic GenomicsMedia
Relations, 619-849-6005
Exxon Mobil (NYSE:XOM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Exxon Mobil (NYSE:XOM)
Historical Stock Chart
From Apr 2023 to Apr 2024